A sensitive ristocetin co-factor activity assay with recombinant glycoprotein Ibα for the diagnosis of patients with low von Willebrand factor levels

Haematologica

Volumn 89, Issue 1, 2004, Pages 77-85

  Federici, Augusto B ^a   Canciani, Maria T ^a   Forza, Ileana ^a   Mannucci, Pier Mannuccio ^a   Marchese, Patrizia ^b   Ware, Jerry ^b   Ruggeri, Zaverio M ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Diagnosis and classification; Ristocetin co factor activity; Von Willebrand factor; Von Willebrand factor activity; Von Willebrand's disease

Indexed keywords

GLYCOPROTEIN IB; MONOCLONAL ANTIBODY; PLATELET GLYCOPROTEIN GP IV IX V COMPLEX; RECOMBINANT GLYCOPROTEIN IB ALPHA; RISTOCETIN; THROMBIN RECEPTOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

AGGLUTINATION TEST; ANIMAL CELL; ARTICLE; BLOOD CLOTTING FACTOR DEFICIENCY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INSECT CELL; MAJOR CLINICAL STUDY; NONHUMAN; PLASMA; VON WILLEBRAND DISEASE;

AGGLUTINATION TESTS; ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE; DROSOPHILA MELANOGASTER; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; TRANSFECTION; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 0842307008     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Sadler JE, Mannucci PM, Berntorp E, Bochkov N, Boulyjenkov V, Ginsburg D, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000;84:160-74.
2. Castaman G, Federici AB, Rodeghiero F, Mannucci PM. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment. Haematologica 2003;88:94-108.
3. Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994;71:520-3.
4. Macfarlane DE, Stibbe J, Kirby E, Zucker MB, Grant RA, McPherson J. A method for assaying von Willebrand factor (ristocetin cofactor). Thromb Diathes Haemorr 1975;34:306-18.
5. Federici AB, Castaman G, Mannucci PM. Guidelines for diagnosis and management of Von Willebrand disease in Italy Haemophilia 2002;8:607-21.
6. Murdock PJ, Woodhams BJ, Matthews KB, Pasi KJ, Goodall AH. von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use. Thrombosis and Haemostasis 1997;78:1272-7.
7. Preston FE. Assays for von Willebrand factor functional activity: a UK NEQAS survey. Thromb Haemost 1998;80:863.
8. Brown JE, Bosak JO. An ELISA test for the binding of von Willebrand Factor antigen to collagen. Thromb Res 1986;43:303-11.
9. Siekmann J, Turecek PIL, Schwartz HP. The determination of von Willebranf Factor activity by collagen binding assay. Haemophilia 1998;4:15-24.
10. Favaloro EJ. Collagen binding assay for von Willebrand factor (VWF:CBA): detection of von Willebrands disease (VWD), and discrimination of VWD subtypes, depends on collagen source. Thromb Haemost 2000;83:127-35.
11. Federici AB, Canciani MT, Forza I, Cozzi G. Ristocetin cofactor and collagen binding activities normalized to antigen levels for a rapid diagnosis of type 2 von Willebrand disease: single center comparison of four different assays. Thromb Haemost 2000;84:1127-8.
12. Vanhoorelbeke K, Cauwenberghs N, Vauterin S, Vauterin S, Deckmyn H. A reliable and reproducible ELISA method to measure ristocetin cofactor activity of von Willebrand factor. Thromb Haemost 2000;83:107-13.
13. Handa M, Titani K, Holland LZ, Roberts JR, Ruggeri ZM. The von Willebrand factor-bindig domain of platelet membrane glycoprotein Ib. Characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments. J Biol Chem 1986;261:12579-85.
14. Murata M, Ware J, Ruggeri ZM. Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ib α demonstrating negatively charged residues involved in von Willebrand factor binding. J Biol Chem 1991;266:15474-80.
15. Celikel R, McClintock RA, Roberts JR, Mendolicchio GL, Ware J, Varughese KI, et al. Modulation of α-thrombin function by distinct interactions with platelet glycoprotein Ibα. Science 2003;301:218-21.
16. Mannucci PM, Lombardi R, Bader R, Vianello L, Federici AB, Solinas S, et al. Heterogeneity of type I von Willebrand's disease: evidence for a subgroup with an abnormal von Willebrand factor. Blood 1985;66:796-802.
17. Mannucci PM, Lombardi R, Castaman G, Dent JA, Lattuada A, Rodeghiero F, et al. Von Willebrand disease Vicenza with larger than normal (supranormal) von Willebrand factor multimers. Blood 1998;71:65-70.
18. Schneppenheim R, Federici AB, Budde U, Castaman G, Drewke E, Mannucci PM, et al. von Willebrand disease type 2M "Vicenza" in Italian and German patients: identification of the first candidate mutation [G3864A; R1205H) in 8 families. Thromb Haemost 2000;83:136-40.
19. Casonato A, Pontara E, Sartorello F, Cattini MG, Sartori MT, Padrini R, et al. Reduced von Willebrand factor survival in type Vicenza von Willebrand disease. Blood 2002;99:180-4.
20. Ribba AS, Loisel I, Lavergne JM, Juhan-Vague I, Obert B, Cherel G, et al. Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen. Thromb Haemost 2001;86:848-54.
21. Riddell AF, Jenkins PV, Nitu-Whalley IC, McCraw AH, Lee CA, Brown SA. Use of the collagen-binding assay for von Willebrand factor in the analysis of type 2M Willebrand disease: a comparison with ristocetin cofactor assay. Br J Haematol 2002;116:187-92.